SCHEMBL30690656

SCHEMBL30690656

Cc1ncc(NC(=O)c2cnc3c(c2)cc(-c2cnn(C)c2)n3COCC[Si](C)(C)C)cc1NC(=O)CN1CCC[C@H](C)C1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 7/20 0.36
DYRK1A Q13627 7/20 0.36
WNT1 P04628 6/20 0.36
AURKB Q96GD4 8/20 0.36
AURKA O14965 7/20 0.36
CHEK1 O14757 3/20 0.36
LCK P06239 3/20 0.36
KDR P35968 3/20 0.36
RPS6KA3 P51812 3/20 0.36
IRAK4 Q9NWZ3 3/20 0.36
CSF1R P07333 1/20 0.36
KIT P10721 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
ALDH1A1 P00352 2/20 0.35
TSHR P16473 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CHRM1 P11229 1/20 0.34
PDGFRA P16234 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30690691 0.98 AURKB (0.37) GSK3BDYRK1AWNT1AURKBAURKA
SCHEMBL30690774 0.89 GSK3B (0.41) GSK3BDYRK1AWNT1CSF1RKIT
SCHEMBL30690769 0.88 GSK3B (0.39) GSK3BDYRK1AWNT1CSF1RKIT
SCHEMBL30690797 0.88 GSK3B (0.44) GSK3BDYRK1AWNT1CSF1RKIT
SCHEMBL30690775 0.85 CSF1R (0.37) GSK3BDYRK1AWNT1CSF1RKIT
SCHEMBL30690658 0.84 CSF1R (0.40) GSK3BDYRK1AWNT1CSF1RKIT
SCHEMBL30690760 0.83 CSF1R (0.40) GSK3BDYRK1AWNT1CSF1RKIT
SCHEMBL30690777 0.81 PDGFRA (0.41) GSK3BDYRK1AWNT1CSF1RKIT
SCHEMBL30690642 0.81 CSF1R (0.41) GSK3BDYRK1AWNT1AURKACSF1R
SCHEMBL30690679 0.80 PDGFRA (0.40) GSK3BDYRK1AWNT1CSF1RKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023247593-A1 PYRROLOPYRIDINE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2023-12-28 WO disclosed